Cytosorbents Corporation

CTSO | NASDAQ

Price Alert Chart Builder DCF Calculator

$5.51

-$0.24 (-4.17%)

At close: Sep 21, 2026, 4:00 PM ET

$5.51

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-4.17%

(1D)

Rating

Updated: Sep 9, 2026

33.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $17.31M

1D Range

5.16 5.79

52W Range

5.13 20.40

Valuation (TTM)

PE -0.96

PB -23.05

EV/EBITDA -2.78

Valuation (NTM)

Forward PE 15.48

Forward PEG 0.01

Price Target $5.38

Cash Flow

FCF Yield -60.2%

SBC Adj. FCF Yield -76.7%

SBC Impact -27.4%

Margins

Gross Margin 71.6%

Operating Margin -33.4%

FCF Margin -28.0%

Growth (CAGR)

Revenue 3Y | 5Y 2.3% | -3.2%

Dil EPS 3Y | 5Y 36.1% | 30.9%

FCF 3Y | 5Y 40.3% | 30.2%

Returns

ROA -48.0%

ROE -445.1%

ROIC -42.4%

Financial Health

Net Debt

$21.92M

Current Ratio 0.66

Interest Coverage -8.86

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous...

Sector Healthcare

Industry Medical - Devices

Employees 149

IPO Date Aug 7, 2006

Website www.cytosorbents.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 12, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Hold

Price Target

$5.38

Downside

-2.36%

Buy (1)

Hold (1)

Sell (0)

Analyst Details ➞